Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Acute Myeloid Leukemia
Research from G. Beadle and co-researchers in the area of acute myeloid leukemia described
March 12th, 2009
"Clinical trials frequently report acute myeloid leukemia (AML) as a complication of adjuvant chemotherapy for breast cancer (BC). This retrospective population-based study investigated AML risk after a prior BC diagnosis and compared the results with women after a prior diagnosis of hematological malignancies (HM), other cancers combined (OCC), and the age-matched Australian female population," scientists writing in the journal Annals of Oncology report. "Women with a prior BC diagnosis had 2.56 times the risk of developing AML compared with the Australian female population (P < 0.001). AML risk was also elevated after prior HM and OCC diagnoses (4.73, P<...
Source: Women's Health Weekly (2009-03-12)
|
